Biotech NewsAnalysts See 127% Upside for Intellia (NTLA) After $14.99 Surge BioTech Health XSeptember 19, 2025 Intellia Therapeutics Inc. (NASDAQ:NTLA) is a pioneering genome editing company founded in 2014 with the mission to develop… 0 Shares 0 0 0 0 0 0 0
Biotech NewsForget Daily Pills—Intellia Therapeutics (NTLA) is Creating Cures You Only Need Once BioTech Health XJuly 1, 2025 Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a biotechnology company at the forefront of a genomic revolution, pioneering the development… 0 Shares 0 0 0 0 0 0 0